Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 29 (3-4), 125-134

Enduring Sexual Dysfunction After Treatment With Antidepressants, 5α-reductase Inhibitors and Isotretinoin: 300 Cases


Enduring Sexual Dysfunction After Treatment With Antidepressants, 5α-reductase Inhibitors and Isotretinoin: 300 Cases

David Healy et al. Int J Risk Saf Med.


Objective: To investigate clinical reports of post-SSRI sexual dysfunction (PSSD), post-finasteride syndrome (PFS) and enduring sexual dysfunction following isotretinoin.

Methods: Data from, a global adverse event reporting website, have been used to establish the clinical features, demographic details and clinical trajectories of syndromes of persistent sexual difficulties following three superficially different treatment modalities.RESULTSWe report on 300 cases of enduring sexual dysfunction from 37 countries following 14 different drugs comprised of serotonin reuptake inhibiting antidepressants, 5α-reductase inhibitors and isotretinoin. While reports of certain issues were unique to the antidepressants, such as the onset of premature ejaculation and persistent genital arousal disorder (PGAD), there was also a significant overlap in symptom profile between the drug groups, with common features including genital anaesthesia, pleasureless or weak orgasm, loss of libido and impotence. Secondary consequences included relationship breakdown and impaired quality of life.CONCLUSIONSThese data point to a legacy syndrome or syndromes comprising a range of disturbances to sexual function. More detailed studies will require developments in coding systems that recognise the condition(s). Further exploration of these tardive sexual syndromes may yield greater understanding of tardive syndromes in general.

Keywords: Post-SSRI sexual dysfunction (PSSD); antidepressants; erectile dysfunction; finasteride; isotretinoin; selective serotonin reuptake inhibitors (SSRIs).

Similar articles

See all similar articles

Cited by 2 PubMed Central articles


    1. Coleman R, MacDonald D. Effects of isotretinoin on male reproductive system. Lancet. 1994;344(8916):198. - PubMed
    1. Bolton JM, Sareen J, Reiss JP. Genital anaesthesia persisting six years after sertraline discontinuation. J Sex Marital Ther. 2006;32(4):327–30. - PubMed
    1. Csoka AB, Shipko S. Persistent sexual side effects after SSRI discontinuation. Psychother Psychosom. 2006;75(3):187–8. - PubMed
    1. Bahrick AS. Post SSRI sexual dysfunction. American Society for the Advancement of Pharmacotherapy Tablet. 2006;7(3):2–3, 10-11.
    1. Kauffman RP, Murdock A. Prolonged post-treatment genital anesthesia and sexual dysfunction following discontinuation of citalopram and the atypical antidepressant nefazodone. The Open Women’ Health Journal. 2007;1:1–3.